title: The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.
abstract: In the search for neuroprotective factors in Huntington's disease, we found that insulin growth factor 1 via activation of the serine/threonine kinase Akt/PKB is able to inhibit neuronal death specifically induced by mutant huntingtin containing an expanded polyglutamine stretch. The IGF-1/Akt pathway has a dual effect on huntingtin-induced toxicity, since activation of this pathway also results in a decrease in the formation of intranuclear inclusions of mutant huntingtin. We demonstrate that huntingtin is a substrate of Akt and that phosphorylation of huntingtin by Akt is crucial to mediate the neuroprotective effects of IGF-1. Finally, we show that Akt is altered in Huntington's disease patients. Taken together, these results support a potential role of the Akt pathway in Huntington's disease.
authors.affiliation: UMR 146 CNRS/Institut Curie, Centre Universitaire, 91405 Orsay Cedex, France.
authors.forename: Sandrine
authors.initials: S
authors.lastname: Humbert
authors.forename: Elzbieta A
authors.initials: EA
authors.lastname: Bryson
authors.forename: Fabrice P
authors.initials: FP
authors.lastname: Cordelières
authors.forename: Nathan C
authors.initials: NC
authors.lastname: Connors
authors.forename: Sandeep R
authors.initials: SR
authors.lastname: Datta
authors.forename: Steven
authors.initials: S
authors.lastname: Finkbeiner
authors.forename: Michael E
authors.initials: ME
authors.lastname: Greenberg
authors.forename: Frédéric
authors.initials: F
authors.lastname: Saudou
mesh_terms: D016923:Cell Death; D002478:Cells, Cultured; D003342:Corpus Striatum / Q000166:cytology; D004789:Enzyme Activation; D006801:Humans; D000071058:Huntingtin Protein; D006816:Huntington Disease / Q000235:genetics / Q000473:pathology*; D002479:Inclusion Bodies / Q000378:metabolism; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D009474:Neurons / Q000166:cytology* / Q000378:metabolism; D009687:Nuclear Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation; D017354:Point Mutation; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D013379:Substrate Specificity
chemical_list: C086055:HTT protein, human; D000071058:Huntingtin Protein; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins; D011993:Recombinant Fusion Proteins; D007334:Insulin-Like Growth Factor I; C494918:AKT1 protein, human; D017346:Protein Serine-Threonine Kinases; D051057:Proto-Oncogene Proteins c-akt